Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

Inclusion Criteria

• •Signed informed consent form providing agreement for germline genetic and molecular testing, use release of health and research information; and
• •Male aged 35 to 89 years; and
• •Diagnosis of prostate cancer; and
• •Resident of Washington state at diagnosis; and
• •Willing to complete a questionnaire (online or on paper) to provide basic demographic information, family cancer history, and health history; and
• •Willing and able to provide a saliva sample; and
• •United States (U.S.) mailing address.
• •Signed informed consent form providing agreement for germline genetic and molecular testing, use release of health and research information; and
• •Male aged 35 to 89 years; and
• •Diagnosis of prostate cancer; and
• •Self-identifies as Black, African American, or African; and
• •Receiving care at UWMC or UWHMC; and
• •Willing and able to provide a saliva sample; and
• •Able to provide either a U.S. mailing address or Email address or Phone number.
• •Signed informed consent form providing agreement for germline genetic and molecular testing, use and release of health and research information; and
• •Males aged 35 to 89 years; and
• •Willingness to complete a questionnaire (online or on paper) to provide basic demographic information, family cancer history, and health history; and
• •Willing and able to provide a saliva sample; and
• •U.S. mailing address